Bayer

Showing 15 posts of 262 posts found.

Get real - rat man

Global Awards wins for Langland

November 25, 2009
Medical Communications Bayer, Langland, Pfizer, awards, counterfeits, get real

Windsor-based advertising agency Langland has won three trophies at the prestigious Global Awards for healthcare communications.Two of these were for …

Blog footer

Digital Pharma: Bayer brings the InBed Dr to YouTube

October 22, 2009
Medical Communications Bayer, digi, digital pharma, digital pharma YouTube

Bayer Schering Pharma has expanded its InBed erectile dysfunction awareness campaign, adding to YouTube 60 short videos that take a …

FDA warns Bayer over German API facility

September 17, 2009
Manufacturing and Production Bayer, FDA, reg

The US regulator has sent a warning letter to Bayer indicating it found "significant deviations from US current good manufacturing …

Bayer has solution for solvent shortage in pharma

August 4, 2009
Manufacturing and Production Bayer

German chemical company Bayer says it could have a solution to help ease the current shortage of acetonitrile, a solvent …

Bayer to launch OTC omeprazole in Germany

July 17, 2009
Sales and Marketing Bayer, OTC

Bayer Vital, the marketing arm of Bayer HealthCare, is to launch the proton pump inhibitor omeprazole as an over-the-counter heartburn …

Bayer signs deal with Celera on cancer targets

June 30, 2009
Research and Development, Sales and Marketing Bayer, Celera

Bayer Schering Pharma has signed a deal with Celera to give it access to five cancer-related targets for therapeutic development …

Genzyme buys rights to Bayer MS candidate

June 4, 2009
Sales and Marketing Bayer, Genzyme

Genzyme has bought the global rights multiple sclerosis (MS) candidate Campath/MabCampath from Bayer HealthCare.Originally discovered by Genzyme, Campath (alemtuzumab) is …

NICE rejects Nexavar for liver cancer

May 7, 2009
Research and Development, Sales and Marketing Bayer, NICE, Nexavar

NICE has rejected Nexavar as a treatment for liver cancer, saying it is not a cost-effective use of NHS resources. …

Bayer launches UK television ads for its morning-after pill

May 6, 2009
Sales and Marketing Bayer

Bayer Schering Pharma has launched a television advertising campaign for its morning-after pill Levonelle One Step in the UK. The …

Bayer Schering’s contraceptive patch enters phase III

May 5, 2009
Research and Development, Sales and Marketing Bayer, sexual health

Bayer Schering is to start phase III trials of its new contraceptive patch and anticipates submitting the product for regulatory …

Nexavar fails in melanoma study

April 30, 2009
Research and Development Bayer, Cancer, Nexavar

Onyx Pharmaceuticals and its development partner Bayer have stopped a phase II trial of Nexavar in patients with late-stage melanoma, …

NICE approves Bayer’s Xarelto

April 23, 2009
Research and Development Bayer, NICE, Xarelto

NICE has approved Bayer's anti-clotting treatment Xarelto, bringing it into line with Boehringer Ingelheim's rival Pradaxa. Xarelto (rivaroxaban) was assessed …

Bayer Schering Pharma restricts UK distribution

April 2, 2009
Manufacturing and Production Bayer

Bayer Schering Pharma has joined the ranks of firms switching to restrictive distribution arrangements in the UK. The pharma company, …

Bayer strikes R&D deal with Chinese university

March 20, 2009
Research and Development Bayer, China, academic research

 Bayer has furthered its R&D expansion in China with an agreement to form a joint pharmaceutical research centre with Tsinghua …

The Gateway to Local Adoption Series

Latest content